|
Volumn 152, Issue 1, 2016, Pages 105-106
|
Eruptive keratoacanthomas associated with leflunomide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENAZEPRIL;
CLOBETASOL PROPIONATE;
CYCLOBENZAPRINE;
DULOXETINE;
ESOMEPRAZOLE;
HYDROMORPHONE;
HYDROXYZINE;
INSULIN;
ISOTRETINOIN;
LEFLUNOMIDE;
MORPHINE SULFATE;
POTASSIUM CHLORIDE;
RITUXIMAB;
ROSUVASTATIN;
ANTIRHEUMATIC AGENT;
ISOXAZOLE DERIVATIVE;
ADULT;
CASE REPORT;
CONSERVATIVE TREATMENT;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE DURATION;
DRUG DOSE REDUCTION;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HUMAN;
KERATOACANTHOMA;
KERATOTIC PAPULE;
LETTER;
MEDICAL HISTORY;
MIDDLE AGED;
NEURODERMATITIS;
PAPULE;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
SKIN BIOPSY;
SKIN DEFECT;
SKIN SURGERY;
TREATMENT OUTCOME;
WOUND CARE;
CHEMICALLY INDUCED;
DRUG ERUPTIONS;
PATHOLOGY;
SKIN TUMOR;
ANTIRHEUMATIC AGENTS;
DRUG ERUPTIONS;
FEMALE;
HUMANS;
ISOXAZOLES;
KERATOACANTHOMA;
MIDDLE AGED;
SKIN NEOPLASMS;
|
EID: 84955324501
PISSN: 21686068
EISSN: None
Source Type: Journal
DOI: 10.1001/jamadermatol.2015.2506 Document Type: Letter |
Times cited : (6)
|
References (4)
|